OTCPK:MEDVF - Post by User
Comment by
lscfaon Jun 12, 2021 1:14am
146 Views
Post# 33377245
RE:RE:RE:Revenue in Q2 +/- $ 12 million
RE:RE:RE:Revenue in Q2 +/- $ 12 million Slide 28 - If we can get the formula right, our revenue model will dramatically improve – we’re projecting a potential upside from the $30 COVID testing cost per patient today, to $300 to $500 per patient – a game changer for our business and for communities across America.
Hiddensecrets wrote: Very recent presentation by David Preiner, only a few weeks old, forecasted revenue of $ 60 million in 2021. Forecast was made in late May 2021.
We had revenue of $ 11 million Q1 which means that we need $ 49 million from the other 3 quarters.
David is a very conservative person and he will not throw out numbers out there for the sake of throwning them out.
When he did the presentation he had an idea of the Q2 revenue run rate and, he also knew of Q1 results, so for him to make this forecast almost 6 months into the year, 2021 of $ 60 million means that he has a pretty good idea of present sales.
You cannot hit $ 60 million in 2021 if we are only going to make $ 1 million per month on covid19 testing from April 1, 2021 to December 31, 2021, there would be missing another $ 40 million in revenue, which he sees and we do not.
I think it will a combination of factors: nuturell, adxit, pharmacy, vaccine, hospitals, etc...
Nuturell on its own can generate $ 60 million if it is in hot demand.
We will know in August 2021.
mpo